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Rickettsia conorii is endemic in Mediterranean area. We describe an unusual sace of R.
Conorii infection, which concerns a farmer with clinical, radiological and cytological
findings of pleurisy without evidence of malignancy. An elevated antibody titre for R.
Conorii was observed, using an indirect immunofluorescent antibody test. After treat-
ment with Doxycycline, the patient presented a significant improvement of his clinical
and radiological image and a four-fold decrease of the antibody titre for R. conorii.
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Mediterranean spotted fever (MSF) is a tick-borne
disease caused by Rickettsia conorii [1,2]. Several
classical clinical features have been proposed to
facilitate the diagnosis in the typical, and usually
mild, forms of the disease [1,2]. However, unusual
manifestations, which have been mainly reported
in the severe forms, complicate the diagnosis [3].
We present an unusual case of pleurisy associated
with antibodies to Rickettsia conorii.
A 30-year-old immunocompetent man, a farmer
from a rural area of northern Greece, presented at
the pulmonary clinic of the Kastoria General Hos-
pital with a 10-day history of headache, low-grade
fever, chills, myalgia, dry cough and left pleuritic
chest pain. The physical examination disclosed
fever (38 8C) and diminished breath sounds over
the left lung. Liver and spleen were not enlarged,
and there were no peripheral lymph nodes palp-
able. No rash was observed. A chest X-ray showed
a pleural effusion without any involvement of the
lungs. The patient received cefuroxime intrave-
nously for 2 days and diclofenac orally, but the
symptoms persisted. Because his condition wor-
sened despite therapy, he was eventually admitted
to the Hippokrates Hospital of Thessaloniki. Dur-
ing his hospitalization, the fever increased (40 8C),
while the rest of the initial symptoms persisted.
Neither rash nor inoculation eschar was observed.
The laboratory studies revealed an elevated C-
reactive protein (CRP) level (78 mg/L), accelerated
erythrocyte sedimentation rate (ESR) (82 mm/h), a
white blood cell count of 24 000/mm3, a platelet
count of 114 000/mm3, and slightly elevated
serum alanine and aspartate aminotransferases,
as well as lactate dehydrogenase (Table 1). Arterial
blood gas measurements were normal. D-Dimer
testing was negative (<0.5 mg/L). The blood and
sputum cultures were negative, and the tuberculin
skin test was also negative.
A CT scan of the thorax (Figure 1) confirmed
the presence of a pleural effusion with pressure
atelectasis of the left lower lung. There were no
abnormal findings in the right lung. Abnormal
mediastinal lymph nodes were not found.
Thoracocentesis and laboratory analysis of the
pleural fluid was performed (Table 1). The cytologic
examination showed no evidence of malignancy.
There was no growth on routine microbiological
culture, and Ziehl–Neelsen staining for acid-fast
bacilli (AFB) and culture on Lowenstein–Jensen
medium were both negative.
The patient received amoxicillin–clavulanic acid
intravenously for 3 days without clinical improve-
ment. The treatment was subsequently changed to
intravenous imipenem and cilastatin sodium and
intravenous prednisolone for 5 days, after which
the patient’s fever declined but the pleural effusion
persisted. The use of a thoracic drainage tube was
not considered, as the patient did not have severe
dyspnea.
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An indirect immunofluorescent (IFA) antibody
test on day 28 after disease onset revealed elevated
IgM and IgG titers for R. conorii (1 : 512 and
1 : 1024, respectively). The Weil–Felix agglutina-
tion test (WFT) using Proteus vulgaris OX-2 anti-
gen was positive at a titer of 1 : 400 and negative
for Proteus vulgaris OX-19 and OX-K antigens.
Tests to detect specific antibodies to influenza
A and B viruses, parainfluenza viruses, adeno-
viruses, respiratory syncytial virus, Epstein–Barr
virus, Mycoplasma pneumoniae, Chlamydia spp.,
Legionella pneumophila, Coxiella burnetti, R. typhi,
human granulocytic ehrlichiosis (HGE) agent and
Leptospira spp. were negative. Widal and Wright
agglutination tests, used for the serologic diagno-
sis of typhoid fever and brucellosis, respectively,
were negative.
As a result, the patient was treated with dox-
ycycline at a dose of 200 mg orally per day. A
significant improvement in his clinical condition
was noted on the third day of treatment. Chest X-
ray showed a decrease in the amount of pleural
fluid. A laboratory follow-up showed reductions
in CRP and ESR (Table 1). The administration of
doxycycline was discontinued 15 days later, when
the patient had already been discharged from the
hospital.
On day 50 after disease onset, a second serum
sample tested by IFA revealed IgG and IgM anti-
bodies to R. conorii at titers of 1 : 256 and 1: 128,
respectively, while WFT using P. vulgaris OX-2 had
increased in titer to 1 : 800. Three months later, in a
third serum sample, the IgG antibody titer to R.
conorii was 1 : 128, whereas no IgM antibodies were
detectable and the WFT was negative.
MSF, also known as boutonneuse fever, was
described in 1910 in Tunis [4]. Tick-borne diseases
are geographically localized, and MSF is found
from southern Europe to southwestern Asia, India,
and Africa [1,2]. The disease is significantly sea-
sonal, with most cases appearing in the spring and
summer months [5,6]. In recent years, there has
been an increasing incidence of MSF in several
Mediterranean countries [5,6]. Seroepidemiologic
studies in the healthy Greek population have
shown a high seroprevalence of R. conorii [7].
Our patient displayed some of the classical symp-
toms of MSF and the infection appeared during the
spring. However, there was no history of tick bite,
and there was no initial black lesion (‘tache noir’),
Variable On admission
After
doxycycline
3 months
later
Blood sampling
C-reactive protein (mg/L) 78 25 <12
Erythrocyte sedimentation rate (mm/
h)
82 40 7
Hematocrit (%) 43 42 42
Platelets (per mm3) 114 000 123 000 288 000
Leukocyte count (per mm3) 24 200 10 000 8600
Neutrophils (%) 76 62 56
Lymphocytes (%) 17 31 37
Monocytes (%) 6 5 6
Eosinophils (%) 1 2 1
Creatinine (mmol/L) 69 71 68
Sodium (mmol/L) 142 141 140
Potassium (mmol/L) 4.3 4.2 4.3
Alanine aminotransferase (U/L) 58 45 24
Aspartate aminotransferase (U/L) 47 42 32
Lactate dehydrogenase (U/L) 248 195 187
Alkaline phosphatase (U/L) 60 62 67
g-Glutamyl transpeptidase (U/L) 35 35 35
Thoracocentesis
Total protein (g/dL) 5.6
Glucose (mmol/L) 3
Lactate dehydrogenase (U/L) 560
Leukocyte count (per mm3) 1200
Neutrophils (%) 73
Lymphocytes (%) 27
pH 71
Table 1 Changes in results of lab-
oratory investigations
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which is of high diagnostic value. However, it is
reported that this characteristic eschar may be
absent in 28% of the patients suffering from
MSF [5,6]. While respiratory involvement is
reported in 30% of Rocky Mountain spotted fever
cases [8], it is quite rare in MSF. Pleurisy caused by
R. conorii infection is an extremely unusual clinical
manifestation [5,6,9,10].
According to Light’s criteria, the pleural effu-
sion was exudative. There was no evidence of
malignancy or pleural tuberculosis [11]. D-Dimer
testing, which is a good screen for pulmonary
emboli, was negative [12].
IFA for the detection of IgM and IgG antibodies
to R. conorii is considered to be the test of choice for
serologic diagnosis, and is used as a reference
technique in most laboratories [13]. The WFT
was the only diagnostic method in the past, but
it is less specific and sensitive, and therefore is not
to be relied on [14]. However, authors often
observe a good correlation between WFT and
the detection of IgM antibodies by IFA [15,16].
We used this test only to support our findings.
The serologic diagnosis of infectious diseases is
usually made by the detection of a significant
increase in antibody titers between the acute
and the convalescent phases of the disease. In
our case, the laboratory diagnosis was established
by the high titers of IgM and IgG antibodies (titers
1 : 512 and 1 : 2048, respectively) to R. conorii on the
28th day of illness, and the fourfold decrease in
antibodies on the 50th day (to titers of 1 : 128 and
1 : 256, respectively). This form of seroconversion
could be explained by the fact that the two serum
samples were obtained during the convalescence
phase of the disease. The patient was treated
with several antibiotics for approximately 30 days,
without any improvement of his clinical condition.
The impressive clinical and radiologic improve-
ment of the patient following the administration
of doxycycline, which is considered to be one of
the most effective antibiotics in rickettsial infec-
tions, also supports the diagnosis [17]. However,
as Rickettsia is known to generate cross-reacting
antibodies, and no other evidence of R. conorii
was found, these symptoms may have been
caused by an unidentified cross-reacting micro-
organism.
Although MSF is endemic in Greece, rickettsio-
sis is not being reported, a fact which may lead
Figure 1 A case of pleurisy caused by Rickettsior conor.
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physicians to underestimate the incidence of the
disease. Despite its rarity, R. conorii infection
should be included in the differential diagnosis
of pleurisy, especially when other infectious
agents are excluded, and treatment with com-
monly used antibiotics fails to improve the
patient’s clinical and radiologic condition.
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